Cargando…
A case report of (131)I therapy for Graves’ disease patient with hemiagenesis
RATIONALE: Thyroid hemiagenesis is a rare congenital dysplasia, whereas a variety of pathological changes may occur in residual thyroid lobe. The most frequently described pathology in residual thyroid lobe is Graves’ hyperthyroidism. Although (131)I therapy has been generally recommended as the pre...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6408000/ https://www.ncbi.nlm.nih.gov/pubmed/30813185 http://dx.doi.org/10.1097/MD.0000000000014606 |